AnorMED to start trading on Nasdaq Global Market

By Jennifer Chiou

New York, Sept. 7 - AnorMED Inc. said its shares will begin trading on the Nasdaq Global Market on Friday.

The Vancouver, B.C., chemistry-based biopharmaceutical company will trade under the symbol "ANOR."

Simultaneously, the company's shares have been de-listed from the American Stock Exchange. AnorMED stock will continue to trade on the Toronto Stock Exchange.

"We are confident that a Nasdaq listing will help the company increase its profile with the world's leading biotechnology investors," chief financial officer Bill Adams said in a news release.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.